Jane Street’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47K | Buy |
+142,597
| New | +$47K | ﹤0.01% | 5108 |
|
|
2025
Q1 | – | Sell |
-14,278
| Closed | -$13.3K | – | 6310 |
|
|
2024
Q4 | $13.3K | Sell |
14,278
-24,121
| -63% | -$22.5K | ﹤0.01% | 5651 |
|
|
2024
Q3 | $45.3K | Sell |
38,399
-60,191
| -61% | -$71K | ﹤0.01% | 5627 |
|
|
2024
Q2 | $75.8K | Buy |
98,590
+45,010
| +84% | +$34.6K | ﹤0.01% | 5680 |
|
|
2024
Q1 | $163K | Buy |
53,580
+2,679
| +5% | +$8.17K | ﹤0.01% | 5107 |
|
|
2023
Q4 | $164K | Buy |
+50,901
| New | +$164K | ﹤0.01% | 5101 |
|
|
2023
Q2 | – | Sell |
-108,615
| Closed | -$280K | – | 5803 |
|
|
2023
Q1 | $280K | Buy |
108,615
+49,497
| +84% | +$128K | ﹤0.01% | 4325 |
|
|
2022
Q4 | $110K | Buy |
59,118
+45,030
| +320% | +$83.8K | ﹤0.01% | 4654 |
|
|
2022
Q3 | $26K | Buy |
14,088
+2,674
| +23% | +$4.94K | ﹤0.01% | 5255 |
|
|
2022
Q2 | $25K | Sell |
11,414
-52,094
| -82% | -$114K | ﹤0.01% | 5066 |
|
|
2022
Q1 | $199K | Buy |
+63,508
| New | +$199K | ﹤0.01% | 4715 |
|
|
2021
Q3 | – | Sell |
-76,973
| Closed | -$301K | – | 5714 |
|
|
2021
Q2 | $301K | Buy |
76,973
+36,862
| +92% | +$144K | ﹤0.01% | 3982 |
|
|
2021
Q1 | $161K | Buy |
+40,111
| New | +$161K | ﹤0.01% | 4391 |
|
|
2020
Q4 | – | Sell |
-35,087
| Closed | -$201K | – | 4258 |
|
|
2020
Q3 | $201K | Buy |
35,087
+5,632
| +19% | +$32.3K | ﹤0.01% | 3224 |
|
|
2020
Q2 | $217K | Sell |
29,455
-24,006
| -45% | -$177K | ﹤0.01% | 3341 |
|
|
2020
Q1 | $160K | Buy |
+53,461
| New | +$160K | ﹤0.01% | 2968 |
|
|
2019
Q3 | – | Sell |
-52,309
| Closed | -$97K | – | 3830 |
|
|
2019
Q2 | $97K | Buy |
52,309
+34,850
| +200% | +$64.6K | ﹤0.01% | 3281 |
|
|
2019
Q1 | $31K | Buy |
+17,459
| New | +$31K | ﹤0.01% | 3184 |
|